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Abstract
Background: Consumption of undercooked or insufficiently cured meat is a major risk factor for human infection
with Toxoplasma gondii. Although horsemeat is typically consumed rare or undercooked, information on the risk of
T. gondii from infected horse meat to humans is scarce. Here, we present the results of a study to determine the
presence of T. gondii infection in slaughter horses in Serbia, and to attempt to isolate viable parasites.
Methods: The study included horses from all regions of Serbia slaughtered at two abattoirs between June 2013 and June
2015. Blood sera were tested for the presence of specific IgG T. gondii antibodies by the modified agglutination test (MAT),
and samples of trypsin-digested heart tissue were bioassayed in mice. Cyst-positive mouse brain homogenates were
subjected to DNA extraction and T. gondii strains were genotyped using 15 microsatellite markers (MS).
Results: A total of 105 slaughter horses were sampled. At the 1:6 cut-off 48.6% of the examined horses were seropositive,
with the highest titre being 1:400. Viable parasites were isolated from two grade type mares; both parasite isolates (RS-Eq39
and RS-Eq40) were T. gondii type III, and both displayed an increased lethality for mice with successive passages. These are
the first cases of isolation of T. gondii from horses in Serbia. When compared with a worldwide collection of 61 type III and
type III-like strains, isolate RS-Eq39 showed a combination of MS lengths similar to a strain isolated from a duck in Iran, and
isolate RS-Eq40 was identical in all markers to three strains isolated from a goat from Gabon, a sheep from France and a pig
from Portugal. Interestingly, the source horses were one seronegative and one weakly seropositive.
Conclusions: The isolation of viable T. gondii parasites from slaughter horses points to horsemeat as a potential source of
human infection, but the fact that viable parasites were isolated from horses with only a serological trace of T.
gondii infection presents further evidence that serology may not be adequate to assess the risk of toxoplasmosis
from horsemeat consumption. Presence of T. gondii type III in Serbia sheds more light into the potential origin of
this archetypal lineage in Europe.
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Background
Toxoplasma gondii is considered one of the most suc-
cessful parasites on Earth due to its omnipresence and
widest array of hosts, including all mammals [1]. The
genus comprises a single species infective for all hosts,
with limited genetic diversity in Europe and North
America where the majority of isolates belong to the
clonal genotypes type II and III, with the predominance
of type II [2, 3]. However, a wider genetic diversity char-
acterized by non-clonal, atypical strains is found in
South America and Africa, and is thought to be related
to the presence of diverse Felidae as the only definitive
host in which sexual reproduction, and consequentially,
genetic recombinations, occur [4, 5].
Human infection is widespread; it has been estimated
that one third of the global population is infected [6].
However, infection is generally mild and self-limiting,
except in population categories with an incompetent
immune system, including the foetus and immunosup-
pressed individuals, in which it may cause life-threatening
disease. Treatment options have not advanced much for
decades and there is still no drug able to eliminate
encysted parasites.
Consumption of undercooked or insufficiently cured
meat is a major risk factor for human infection with T.
gondii [7–11].
Horsemeat is typically consumed rare or undercooked,
particularly in some European countries such as Italy
and France [12]. Serbia used to be an important horse
producer and exporter, but the production has been sig-
nificantly decreasing over the last decades. Local con-
sumption of horsemeat currently constitutes about 0.01
kg per capita per year [13]. The presence of T. gondii in
main meat producing animals in Serbia has been well
established [14–16], but for horses there are very few
data [14], and moreover, horse meat or tissues have not
yet been analysed. Several strains originating from
patients, as well as from pigs, sheep, rodents and pi-
geons have been already isolated and genotyped [17–20].
Viable cysts have been shown to persist for many
months in various organs in experimentally infected
horses [21].
Here, we present the results of a study to examine the
presence of T. gondii infection in slaughter horses in
Serbia, and to attempt to isolate viable parasites.
Methods
Study population and collection of samples
The total number of horses in Serbia is around 15,000
[22], of which about 400 are slaughtered each year.
While no abattoir exclusively slaughters horses, those
that do, usually slaughter them at a rate of once to twice
per week. In this study, samples were obtained from
horses slaughtered in two abattoirs, one in Northern
Serbia and the other in the vicinity of Belgrade,
between June 2013 and June 2015. The sampled ma-
terials included blood and heart tissue. The heart
was chosen for sampling as it was identified as a
predilection site [23]. Blood (8 ml) was collected in
sterile centrifuge tubes (with no additive) during ex-
sanguination at the slaughter line. The apex portion
of the heart (at least 300 g) was collected into a
sample bag. Each animal was designated with a
unique ID number and the samples were labelled
accordingly. Samples were transported on ice to the
Serbian National Reference Laboratory for Toxoplas-
mosis (NRL Toxo) immediately after collection.
Upon arrival, each blood sample was centrifuged at
800× g for 20 min, and the collected sera were
immediately frozen and kept at -80 °C until testing
for T. gondii antibodies. Heart tissue was processed
immediately or kept at +4 °C until processing the
following day.
Collection of zoographical data
Data on horses were collected from the accompanying
health certificates and included age, gender and region
of origin of the animal. Horses were classified by age as
yearlings (1–2 years), young (3–4 years) or adult (5–9
years old). The regions of origin included Northern,
Western, Central and Eastern Serbia, and “not deter-
mined”, for horses brought for slaughter by traders who
kept them just for a short time after purchase. Deter-
mination of horse type or breed was based on direct
observation of the horses prior to slaughter, and on
interview of the horse trader when present; horses were
classified as grade (no dominant breed trait; for general
use or light work only), working (used for medium work,
dominantly Bosnian horse or Nonius breed mixes), and
working heavy-type cold blooded horses.
Study design
Horse sera were sent to the French National Reference
Centre for Toxoplasmosis (NRC Toxo) laboratory in
Reims, where they were tested for specific IgG T. gondii
antibodies. Heart samples were processed (at Serbian
NRL Toxo) by trypsin digestion, and the digests inocu-
lated into mice for bioassay. Following a 6-week
observation period, the mice were euthanized, and sera
tested for T. gondii antibodies, while brains were exam-
ined microscopically for T. gondii cysts. If cysts were
observed, a portion of the brain homogenate was saved
for DNA extraction for genotyping, and the rest re-
inoculated into fresh mice for strain propagation. Finally,
the DNA samples extracted from the mouse brain ho-
mogenates were sent to the Biological Resource Centre
Toxoplasma (BRC) in Limoges for strain genotyping.
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Serology
T. gondii-specific IgG antibodies were detected by a
modified agglutination test (MAT) as described by
Desmonts and Remington [24], the antigen for which
was prepared by NRC Toxo in Reims. Horse sera were
tested at NRC Toxo, at starting dilutions of 1:6, 1:10 and
1:25, and two-fold dilutions thereafter if needed.
Mouse sera were tested at the NRL Toxo in Belgrade,
using the same protocol, but starting at a 1:20 dilution.
Trypsin digestion
Heart tissue samples were trimmed to remove any ex-
cess fat and connective tissue, and cut into roughly 2 × 2
cm cubes. A total of 200 g of tissue was weighed out
and coarsely blended in a food processor. The minced
tissue was digested with 0.25% porcine trypsin (T4674,
Sigma-Aldrich, St. Louis, MO, USA) in sterile saline
(final volume of 300 ml), supplemented with 200×
penicillin-streptomycin solution (PAA Laboratories
GmbH, Pasching, Austria), and 27 μg/ml amoxicillin
(Hemofarm, Vršac, Serbia). The digestion was performed
at 37 °C for 1.5 h with continuous stirring. Next, the
suspension was filtered through sterile gauze; the flow-
through was collected and washed three times with
sterile saline, in between centrifugations for 10 min at
1,800× g at 4 °C. This resulted in a 3–10 ml pellet. To
prevent carry-over contamination during processing,
knives, all utensils and the food processor were
thoroughly washed between samples with a detergent
solution, followed by decontamination with a 10% hypo-
chlorite solution and finally rinsing with distilled water.
Mice (for bioassay)
For parasite isolation, female Swiss-Webster mice
(Medical Military Academy Animal Research Facility,
Belgrade) were used. Mice, weighing 18–20 g at the
beginning of each experiment, were housed at the Insti-
tute for Medical Research Animal Research Facility at
two per cage, and offered regular mouse feed and drink-
ing water ad libitum. Naïve mice are occasionally exam-
ined for T. gondii infection at random for various
purposes, and none were ever shown to be infected.
Bioassay
Bioassays were performed as described previously [25].
Briefly, 1 ml of the heart tissue digest pellet supple-
mented with gentamicin was inoculated intraperitoneally
(i.p.) into two naïve mice each per heart. Mice were
monitored daily over a period of 6 weeks; peritoneal
fluid of those that needed to be euthanized was exam-
ined for the presence of T. gondii tachyzoites, and
microbiological culture of peritoneal fluid was per-
formed. After 6 weeks mice were euthanized, blood sam-
ples taken for serology, and brains homogenized with 1
ml of saline each for cyst enumeration and, in case of
positive findings, for DNA extraction, and subinocula-
tion for further propagation. Cysts were counted under a
phase-contrast microscope in four 25 μl drops of the
brain suspensions, giving a threshold sensitivity of our
method of 10 cysts/ml of brain homogenates. A bioassay
was considered positive if at least one T. gondii cyst was
detected in either mouse.
The remaining homogenate from cyst negative bioas-
says was frozen, while homogenates from cyst positive
bioassays were prepared for per os inoculation into 4
naïve mice (2 to 5 cysts per mouse) for subsequent
passage and strain genotyping.
The bioassay protocol used was approved by the State
Ethics Committee (Veterinary Directorate of the Minis-
try of Agriculture and Environmental Protection of
Serbia decision no. 323-07-02446/2014-05/1) and a local
Ethics Committee (0313-1/11).
DNA extraction and microsatellite analysis and
Neighbour-joining clustering
Strains which were successfully established after initial
bioassay and 1st passage were genotyped using MS ana-
lysis. Briefly, total genomic DNA was extracted from 100
μl of mouse brain homogenates using the NucleoSpin®
Tissue (mini) kit (Macherey-Nagel, Düren, Germany),
according to the manufacturer’s instructions. The result-
ing gDNA was re-suspended in a total volume of 100 μl
of elution buffer and stored at -20 °C until shipment to
BRC in Limoges. The isolates were genotyped based on
length polymorphisms of 15 MS markers distributed on
10 of 14 chromosomes, as described previously [26].
For comparison, we included the genotyping data of
all 61 strains with type III or type III-like genotypes
(only excluding clones, i.e. repeat genotypes within the
same locality), available at the BRC from Limoges, col-
lected in Europe, the Americas, Africa/Middle East and
Asia/Oceania (see Additional file 1: Table S1), seven of
which have not been published previously. These 61
strains were collected from different animal species, or
were isolated from patients with congenital toxoplasmo-
sis (CT) by the French NRC Toxo. An unrooted
neighbour-joining tree was reconstructed from MS data
with Populations 1.2.32 (http://bioinformatics.org/popu-
lations/) based on Cavalli-Sforza and Edwards chord-
distance estimator [27] and generated with MEGA 6.05
(http://www.megasoftware.net/history.php).
Statistical analysis
For the analysis of serological results, 95% confidence in-
tervals were calculated. The influence of examined vari-
ables on T. gondii seropositivity was analysed by Chi-
square test. The possible influence of age (expressed in 5
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two-year increments) on T. gondii seropositivity was
analysed by Spearman’s rank correlation.
The level of significance was 5%. All statistics were
performed using the SPSS version 11.5 statistical pack-
age (SPSS Inc., Chicago, IL, USA).
Results
The study series involved a total of 105 slaughter horses
of both sexes ranging from 10 months to 9 years of age
(mean 6.1 ± 1.8 years, median 6 years). The sampled
population size represents over 13% of the estimated
total number of horses slaughtered in Serbia during the
sampling period. Seropositivity to T. gondii infection tak-
ing the lowest serum dilution (1:6) as the cut-off value
was 48.6% (51/105), with the highest titre being 1:400
(Fig. 1). However, by raising the cut-off value to the 1:25
dilution, the seropositivity decreased to 12.4% (13/105).
Analysis of the zoographic variables showed that
neither age group, gender, type/use, region nor slaugh-
terhouse (place of sampling) had any influence on T.
gondii seropositivity, as estimated at both the 1:6
(Table 1) and 1:25 cut-off (data not shown). The
observed inter-regional differences (with the highest
seropositivity recorded in Western Serbia) were not sig-
nificant, presumably due to the small subgroups. There
was no influence of age (rank) of the horses, either
(Spearman rank correlation: ρ (103) = -0.0398, P = 0.687).
Bioassays were completed for 104 of the 105 horses,
because in one bioassay both mice died on day 2 and 3
post infection, respectively, with large numbers of
Streptococcus equi and Pseudomonas spp. bacteria
cultured from the peritoneal exudates (pex). T. gondii
tissue cysts were detected from two grade type mares of
“undetermined” origin, slaughtered at the same abattoir
but on different days. Interestingly, one of these tested
negative for T. gondii antibodies, and the other was posi-
tive only at the 1:6 dilution (Table 2). All three mice
harbouring detectable T. gondii brain cysts were sero-
positive at high titres (≥ 1:5120), while, conversely, no
specific antibodies were detected in any of the mice from
cyst-negative bioassays. Both strains (RS-Eq39 and RS-
Eq40) were successfully passaged after initial isolation
and have since been maintained at the NRL Toxo. Of
note, both displayed an increased lethality for mice with
successive passages. Although all mice inoculated with
horse heart digests survived without clinical symptoms
for 6 weeks while developing hundreds of cysts, mice
started succumbing to the infection as of the first subse-
quent passage. The inoculum was thereafter lowered to
3 then 2 cysts for RS-Eq39, and to 4 and 3 cysts for RS-
Eq40.
Microsatellite analyses
MS genotyping analysis showed both isolates to be type
III. These strains were compared to a collection of 61
type III and type III-like strains available at the BRC
from Limoges (Additional file 1: Table S1). The RS-Eq39
strain showed less frequent alleles for markers M48 and
N61 than most type III strains isolated in Europe, and
was most closely related to a strain isolated from a duck
in Iran, IR-Duck38. The strain RS-Eq40 was identical to
strains TgA105011 (goat from Gabon), TgA32122 (sheep
from France) and TgPiPr14 (pig from Portugal) in all
MS marker lengths (Additional file 1: Table S1). Figure 2
depicts an unrooted tree obtained by neighbour-joining
analysis of the 63 strains.
Interestingly, both RS-Eq39 and RS-Eq40 differ from
the other mentioned type III strain previously isolated
from a pigeon in Serbia, RS-G13, which showed uncom-
mon alleles for markers N60 and M102 with respect to
Fig. 1 Distribution of Toxoplasma gondii antibody levels in seropositive slaughter horses in Serbia
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the other strains isolated in Europe and was actually
most closely related to a strain isolated from a sheep in
Iran (IR-Sheep68) (Fig. 2).
Comparative MS marker analysis of genotypes of all
63 type III and type III-like isolates from Europe, the
Americas, Africa, Asia and Oceania (Additional file 1:
Table S1) revealed 59 distinct genotypes. Of the 63
analysed strains, a total of three were isolated from
horses, which, in addition to the two from Serbia, in-
clude an isolate from horsemeat (TgA21035) imported
from Canada into France [28].
Discussion
This study showed a T. gondii seropositivity in horses
from Serbia of almost 50% at a 1:6 MAT cut-off value,
and 12.4% at 1:25 as the cut-off value. The value
obtained at the 1:25 cut-off is significantly lower than
the 30.8% seroprevalence found in an earlier study [14]
(performed with the same test at the same cut-off ) and
probably reflects the difference in the age of the horses,
since the animals in the present study were significantly
younger (P = 0.00056). Worldwide, the reported sero-
prevalence in horses ranges from 0 to 100%, and from 0
to 53% in Europe (rev. in [29, 30]). Recent studies in
Europe have shown seropositivity rates of 1.7% in Greece
[31], 10.8% in Spain [32], 3% [33] and 17.6% in Italy
[34], 23% in the Czech Republic [35], 37.8% in Romania
[36], and from 13 to 90% (depending on the cut-off ) in
France [37]. It is difficult to assess whether the reported
data represent real differences in the seroprevalence of
T. gondii infection or possibly reflect the use of different
assays, different cut-offs for modified agglutination
Table 1 Toxoplasma gondii-specific antibodies as determined by the modified agglutination test (cut-off 1:6) in slaughter horses in
Serbia according to zoographic characteristics
Variable n Seroprevalence (%) 95% CI Chi-square P-value
Age group
Yearling (1–2 years) 4 25.0 0–67.4 0.309
Young (3–4 years) 14 64.3 39.2–89.4
Adult (5–9 years) 87 47.1 36.6–57.6
Gender
Female 51 43.1 29.5–56.7 0.279
Male 54 53.7 40.4–67
Type/use
Grade 79 50.6 39.6–61.6 0.723
Working 8 37.5 3.9–71
Working, heavy 18 44.4 21.4–63.3
Region
Northern Serbia 10 30.0 1.6–58.4 0.233
Western Serbia 10 70.0 41.6–98.4
Central Serbia 13 30.8 5.7–55.9
Eastern Serbia 16 43.7 19.4–68.1
Undetermined/Traders’ 56 53.6 40.5–66.6
Slaughterhouse
A 56 51.8 38.7–64.9 0.481
B 49 44.9 31–58.8
Total 105 48.6 39–58.1
Table 2 Source animal characteristics and strain mouse bioassay and genotyping results of the two Toxoplasma gondii strains
isolated from the hearts of slaughter horses in Serbia
Gender Age Type/use MAT (horse sera) Bioassay Genotype
Mouse 1 Mouse 2
Brain cysts/ml MAT Brain cysts/ml MAT
Mare 6 Grade < 1:6 1010 1:20480 320 1:20480 III
Mare 4 Grade 1:6 690 1:5120 0 < 1:20 III
Klun et al. Parasites & Vectors  (2017) 10:167 Page 5 of 9
assays or perhaps intrinsic differences in the study sam-
ples regarding age and/or true origin of the animals.
Despite numerous serological data, reports of T. gondii
isolations from naturally infected horses are quite rare.
Interestingly, first isolations come from 50 years ago
[38–40], but after a long gap, the last few years have
seen a renewed interest in this issue. In Brazil, T. gondii
was detected in the brains of 3.5% (14/398) horses by
mouse bioassay, according to presence of parasites in
two mice (in brain and pex one each) or mouse IFAT
seropositivity alone (in 12 cases) [41]. In Europe, two
strains have only recently been isolated from the hearts
of seropositive slaughter horses in Romania (by mouse
bioassay), but were not genotyped [36]. In Italy, Papini
et al. [34] have isolated three strains and genotyping by
PCR-RFLP showed them to be of type I, II/III and III re-
spectively. The isolation of two viable T. gondii strains
from slaughter horses in Serbia described here is the first
report in this country. It is interesting that both isolates
belong to type III.
Archetypal type III and type III-like strains or DNA
have been obtained from animals and human CT cases
in Europe, and throughout the world (Additional file 1:
Table S1). The two strains from Serbian horses are of
archetypal type III, with the RS-Eq40 isolate sharing an
identical MS genotype with strains with a very different
geographical origin, within or from out of Europe
(Gabon: TgA105011, France: TgA32122, Portugal:
TgPiPr14), while the RS-Eq39 was most closely related
to a strain isolated from a duck in Iran, IR-Duck38
(Additional file 1: Table S1; Fig. 2). This observed simi-
larity between geographically distant strains may reflect
recent clonal expansions of the Type III. On the other
hand, in comparison to the only other horse isolate
TgA21035 (a type III-like, from Canada), our two strains
show differences on even 6 MS markers (B18, M48,
M102, N60, AA, N83), demonstrating a different origin
of these strains.
A worldwide distribution of type III T. gondii strains
may be attributed to the proposed ancestral nature of
type III relative to the other archetypal lineages [42, 43].
In Europe type III has mostly been isolated in Mediter-
ranean countries (Additional file 1: Table S1) [44–49].
Its more frequent representation in the Mediterranean
perimeter is further suggested by the present isolation of
type III strains from horses and a previous one from a
feral pigeon in Serbia [20]. These findings point to the
possibility of importation of strains, sometime in the
Fig. 2 Neighbour-joining clustering of Toxoplasma gondii isolates based on 15 microsatellite markers. Red points are for isolates from Europe (n= 19);
yellow points are for isolates from South and Central America (n= 14); blue points are for isolates from North America (n= 9); green points are for isolates
from Asia and Oceania (n= 2); black points are for isolates from Africa and the Middle East (n= 19); arrows are for strains isolated from horses: two in this
study (RS-Eq39 and RS-Eq40) and one in a previous study (TgA21035)
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distant past, perhaps originally from Africa, where type
III is common both in urban and rural environments
[3, 43]. Moreover, type III strains were isolated, more
frequently than type II strains, from birds in Egypt and
Iran [50, 51]. It is therefore possible that migratory birds
have contributed to the spread of type III T. gondii into
Europe. A more recent factor that may facilitate the
spread of T. gondii of different genotypes throughout the
world is globalization of trade and transportation.
The results of this study also present interesting infor-
mation on the virulence of the isolated type III strains.
The isolates themselves were initially of a weakly viru-
lent phenotype; such type III strains have been described
in Gabon (TgA105011 equals GAB1-2007-CAP-AEG6 in
Mercier et al. [43]) and French Guiana (A. Mercier,
unpublished data). However, our horse isolates seem
unique in that their virulence increased in subsequent
oral passages. An increase in T. gondii pathogenicity in
mice has been historically documented following fre-
quent i.p. passage, notably with type III strains [52], but
oral inoculation has frequently led to a decrease in viru-
lence [25].
Data regarding the risk of transmission of T. gondii
from infected horse meat to humans are scarce and in-
ferred. In France, Pomares et al. [28] described three
cases of human toxoplasmosis, in which MS genotyping
showed all three to be different atypical strains, and epi-
demiologic explorations revealed that the probable
source of infection was eating raw horsemeat, in two
cases imported from Canada and Brazil, respectively.
The risk was further emphasized by the isolation of a
type III-like strain from horsemeat (originating from
Canada) obtained from the first patient’s butcher [28].
Using MC-PCR, Aroussi et al. [37] detected T. gondii
DNA in 43% of 231 horsemeat samples from French
supermarkets. Strain isolation was attempted from 118
samples by mouse bioassay, but no parasites were iso-
lated, which the authors considered to reflect low distri-
bution of cysts in skeletal muscles, therefore indicating a
low risk of human T. gondii infection from consuming
infected horsemeat [37]. However, quite the opposite
was concluded in a study of the relative contribution of
sheep, beef and pork products to human T. gondii infec-
tion in the Netherlands (as quantified by Quantitative
Microbial Risk Assessment), which showed a high public
health risk even in the case of low prevalence of parasite
cysts in animal tissues, if the meat is inadequately
processed [53]. Therefore, as horsemeat is generally
consumed rare or undercooked, the risk for human in-
fection may be high even in the case of low cyst burden
in horse tissues.
In the case of isolations in Serbia, a low cyst burden
may indeed explain the low isolation rate in view of the
high seroprevalence, at least as estimated according to
the low MAT cut-off [54]. However, a low cut-off of 1:10
was shown to give the best sensitivity/specificity balance
between the MAT test and the presence of T. gondii
DNA in meat samples as detected by MC-PCR [37]. An-
other important point is that the strains we isolated orig-
inated from one weakly seropositive animal and from
another completely seronegative one. This, however,
agrees with the results of a recent systematic review
which has shown very low agreement between sero-
logical results and the presence of T. gondii cysts espe-
cially in large animals including cattle and horses, with a
low recovery rate in seropositives and similar rates of
direct detection of the parasite in seronegative and sero-
positive animals [23].
Conclusions
The isolation of viable T. gondii parasites from slaughter
horses points to horsemeat as a possible and even prob-
able source of human infection, a conclusion recently
reached by a systematic review [55] as well. Moreover,
successful isolations from horses with feeble serological
evidence of T. gondii infection seem to confirm the no-
tion [37] that the use of serological tests may not be rec-
ommended to assess the risk of human toxoplasmosis
from consumption of horsemeat, which further limits
the currently available tools to detect animals that may
pose a threat to human health. Given that horsemeat
tends to be consumed rare, the role of slaughter horses
as sources of T. gondii infection should not be disre-
garded. Presence of T. gondii type III in Serbia sheds
more light into the potential origin of this archetypal
lineage in Europe.
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Abbreviations
95% CI: 95% confidence interval; BRC: Biological Resource Centre Toxoplasma;
CT: Congenital toxoplasmosis; DNA: Deoxyribonucleic acid;
i.p.: Intraperitoneal; IFAT: Immunofluorescence antibody test; MAT: Modified
agglutination test; MC-PCR: Magnetic capture-polymerase chain reaction;
MS: Microsatellite; NRC Toxo: National Reference Centre for Toxoplasmosis
(France); NRL Toxo: National Reference Laboratory for Toxoplasmosis (Serbia);





This study was conducted by a consortium within the framework of project
n° GA/EFSA/BIOHAZ/2013/01 grant agreement, entitled “Relationship
between seroprevalence in the main livestock species and presence of
Toxoplasma gondii in meat”, funded by the European Food Safety Authority.
This publication is partly based on the results obtained in the framework of
this project, published under the sole responsibility of the authors, and shall
Klun et al. Parasites & Vectors  (2017) 10:167 Page 7 of 9
not be considered as an EFSA output. The study was also funded by the
Ministry of Education, Science and Technological Development of Serbia
(project No. III 41019).
Availability of data and materials
The datasets supporting the conclusions of this article are included within
the article and its Additional file 1: Table S1.
Authors’ contributions
ODjDj and IK conceived and designed the study and wrote the first draft of
the manuscript. JvdG, RB and MO participated in the study design. AM
participated in writing of the manuscript. The procedures were performed by
IK and IR (sampling, trypsin digestion, mouse bioassays and serology), AU
(DNA extraction), IV and DA (serology), BB and AN (microscopy – cyst
detection), and AM (microsatellite genotyping). IK, AU, AM, and ODjDj
analysed the data. JvdG, MO, RB, IV and DA critically revised the manuscript.
All authors read and approved the final manuscript.
Competing interests




The bioassay protocol used was approved by the State Ethics Committee
(Veterinary Directorate of the Ministry of Agriculture and Environmental
Protection of Serbia decision no. 323-07-02446/2014-05/1).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1National Reference Laboratory for Toxoplasmosis, Centre of Excellence for
Food- and Vector-Borne Zoonoses, Institute for Medical Research, University
of Belgrade, Dr Subotića 4, 11129 Belgrade, Serbia. 2Centre National de
Référence de la Toxoplasmose, Laboratoire de Parasitologie-Mycologie, CHU
Maison Blanche, EA 3800 SFR CAP-SANTE, UFR Médecine Université de Reims
Champagne-Ardenne, 45 rue Cognacq-Jay, 51092 Reims, France. 3INSERM,
UMR_S 1094, Neuroépidémiologie Tropicale, Université de Limoges, 2 rue du
Docteur Marcland, 87025 Limoges, France. 4Toxoplasma Biological Resource
Center (BRC), Centre Hospitalier-Universitaire Dupuytren, 87042 Limoges,
France. 5National Institute for Public Health and the Environment (RIVM),
Antonie van Leeuwenhoeklaan 9, 3520BA Bilthoven, Netherlands. 6Ecole
Nationale Vétérinaire d’Alfort, UMR BIPAR, ANSES, INRA, Université Paris-Est,
Laboratoire de santé animale de Maisons-Alfort, Maisons-Alfort, France.
Received: 7 December 2016 Accepted: 23 March 2017
References
1. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to
humans. Int J Parasitol. 2000;30:1217–58.
2. Ajzenberg D. Type I, strains in human toxoplasmosis: myth or reality? Future
Microbiol. 2010;5:841–3.
3. Shwab EK, Zhu XQ, Majumdar D, Pena HF, Gennari SM, Dubey JP, Su C.
Geographical patterns of Toxoplasma gondii genetic diversity revealed by
multilocus PCR-RFLP genotyping. Parasitology. 2014;141:453–61.
4. Sibley LD, Khan A, Ajioka JW, Rosenthal BM. Genetic diversity of Toxoplasma
gondii in animals and humans. Philos Trans R Soc Lond B Biol Sci. 2009;364:
2749–61.
5. Su C, Khan A, Zhou P, Majumdar D, Ajzenberg D, Dardé ML, et al. Globally
diverse Toxoplasma gondii isolates comprise six major clades originating
from a small number of distinct ancestral lineages. Proc Natl Acad Sci USA.
2012;109:5844–9.
6. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965–76.
7. Desmonts G, Couvrer J, Alison F, Baudelot J, Gerbeaux J, Lelong M. Étude
épidémiologique sur la toxoplasmose: de l’influence de la cuisson des
viandes de boucherie sur la fréquence de l’infection humaine. Rev Fr Etud
Clin Biol. 1965;10:952–8.
8. Bobić B, Jevremović I, Marinković J, Šibalić D, Djurković-Djaković O. Risk
factors for Toxoplasma infection in a reproductive age female population in
the area of Belgrade, Yugoslavia. Eur J Epidemiol. 1998;14:605–10.
9. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al.
Sources of Toxoplasma infection in pregnant women: a European
multicentre case-control study. Br Med J. 2000;15:142–7.
10. Bobić B, Nikolić A, Klun I, Vujanić M, Djurković-Djaković O. Undercooked
meat consumption remains the major risk factor for Toxoplasma infection in
Serbia. Parassitologia. 2007;49:227–30.
11. Jones JL, Dubey JP. Foodborne toxoplasmosis. Clin Infect Dis.
2012;55:845–51.
12. Boireau P, Vallee I, Roman T, Perret C, Mingyuan L, Gamble HR, Gajadhar A.
Trichinella in horses: a low frequency infection with high human risk. Vet
Parasitol. 2000;93:309–20.
13. Statistical office of the Republic of Serbia (RZS). The consumption of meat
and meat products in Serbia - household budget surveys raw data (2003–
2009). http://pod2.stat.gov.rs/ObjavljenePublikacije/G2010/pdf/G20105526.
pdf. Accessed 19 Mar 2010.
14. Klun I. Seroepizootiological study of Toxoplasma gondii infection in
ungulates in Serbia. Belgrade: Master’s thesis, University of Belgrade School
of Veterinary Medicine; 2005.
15. Klun I, Djurković-Djaković O, Katić-Radivojević S, Nikolić A. Cross-sectional
survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia:
seroprevalence and risk factors. Vet Parasitol. 2006;135:121–31.
16. Klun I, Vujanić M, Yera H, Nikolić A, Ivović V, Bobić B, et al. Toxoplasma
gondii infection in slaughter pigs in Serbia: seroprevalence and
demonstration of parasites in blood. Vet Res. 2011;42:17.
17. Djurković-Djaković O, Klun I, Khan A, Nikolić A, Knezević-Ušaj S, Bobić B,
Sibley LD. A human origin type II strain of Toxoplasma gondii causing severe
encephalitis in mice. Microbes Infect. 2006;8:2206–12.
18. Vujanić M, Ivović V, Kataranovski M, Nikolić A, Bobić B, Klun I, et al.
Toxoplasmosis in naturally infected rodents in Belgrade, Serbia. Vector
Borne Zoonotic Dis. 2011;11:1209–11.
19. Štajner T, Vasiljević Z, Vujić D, Marković M, Ristić G, Mićić D, et al. Atypical
strain of Toxoplasma gondii causing fatal reactivation after haematopoietic
stem cell transplantion in a patient with an underlying immunological
deficiency. J Clin Microbiol. 2013;51:2686–90.
20. Marković M, Ivović V, Stajner T, Djokić V, Klun I, Bobić B, et al. Evidence for
genetic diversity of Toxoplasma gondii in selected intermediate hosts in
Serbia. Comp Immunol Microbiol Infect Dis. 2014;37:173–9.
21. Dubey JP. Persistence of encysted Toxoplasma gondii in tissues of equids
fed oocysts. Am J Vet Res. 1985;46:1753–4.
22. Anon. Number of livestock and beehives, 2013–2015. In: Statistical Yearbook
of the Republic of Serbia. Statistical Office of the Republic of Serbia (RZS).
2016. http://pod2.stat.gov.rs/ObjavljenePublikacije/G2016/pdf/G20162019.
pdf. Accessed 15 Nov 2016.
23. Opsteegh M, Maas M, Schares G and van der Giessen J on behalf of the
consortium. Relationship between seroprevalence in the main livestock
species and presence of Toxoplasma gondii in meat (GP/EFSA/BIOHAZ/
2013/01). An extensive literature review. Final report. EFSA Supporting
Publications. 2016;13. doi:10.2903/sp.efsa.2016.EN-996.
24. Desmonts G, Remington JS. Direct agglutination test for diagnosis of
Toxoplasma infection: method for increasing sensitivity and specificity. J Clin
Microbiol. 1980;11:562–8.
25. Djurković-Djaković O, Nikolić A, Bobić B, Klun I, Aleksić A. Stage conversion
of Toxoplasma gondii RH parasites in mice by treatment with atovaquone
and pyrrolidine dithiocarbamate. Microbes Infect. 2005;7:49–54.
26. Ajzenberg D, Collinet F, Mercier A, Vignoles P, Dardé ML. Genotyping of
Toxoplasma gondii isolates with 15 microsatellite markers in a single
multiplex PCR assay. J Clin Microbiol. 2010;48:4641–5.
27. Cavalli-Sforza LL, Edwards AW. Phylogenetic analysis. Models and estimation
procedures. Am J Hum Genet. 1967;19:233–57.
28. Pomares C, Ajzenberg D, Bornard L, Bernardin G, Hasseine L, Darde ML,
Marty P. Toxoplasmosis and horse meat, France. Emerg Infect Dis.
2011;17:1327–8.
29. Dubey JP, Beattie CP. Toxoplasmosis in equids. In: Toxoplasmosis of animals
and man. Boca Raton: CRC Press; 1988. p. 143–6.
30. Dubey JP. Toxoplasmosis in horses (Equus caballus). In: Toxoplasmosis of
animals and humans. 2nd ed. Boca Raton: CRC Press; 2010. p. 177–8.
31. Kouam MK, Diakou A, Kanzoura V, Papadopoulos E, Gajadhar AA,
Theodoropoulos G. A seroepidemiological study of exposure to Toxoplasma,
Klun et al. Parasites & Vectors  (2017) 10:167 Page 8 of 9
Leishmania, Echinococcus and Trichinella in equids in Greece and analysis of
risk factors. Vet Parasitol. 2010;170:170–5.
32. García-Bocanegra I, Cabezón O, Arenas-Montes A, Carbonero A, Dubey JP,
Perea A, Almería S. Seroprevalence of Toxoplasma gondii in equids from
Southern Spain. Parasitol Int. 2012;61:421–4.
33. Bártová E, Machačová T, Sedlák K, Budíková M, Mariani U, Veneziano V.
Seroprevalence of antibodies of Neospora spp. and Toxoplasma gondii in
horses from southern Italy. Folia Parasitol. 2015;6:62.
34. Papini RA, Buzzone G, Nardoni S, Rocchigiani G, Mancianti F. Seroprevalence
and genotyping of Toxoplasma gondii in horses slaughtered for human
consumption in Italy. J Equine Vet Sci. 2015;35:657–61.
35. Bártová E, Sedlák K, Syrová M, Literák I. Neospora spp. and Toxoplasma
gondii antibodies in horses in the Czech Republic. Parasitol Res.
2010;107:783–5.
36. Paştiu AI, Györke A, Kalmár Z, Bolfă P, Rosenthal BM, Oltean M, et al.
Toxoplasma gondii in horse meat intended for human consumption in
Romania. Vet Parasitol. 2015;212:393–5.
37. Aroussi A, Vignoles P, Dalmay F, Wimel L, Dardé ML, Mercier A, Ajzenberg D.
Detection of Toxoplasma gondii DNA in horse meat from supermarkets in
France and performance evaluation of two serological tests. Parasite.
2015;22:14.
38. Zardi O, Sulli E, Venditti G, Giorgi G. Epidemiological studies on
toxoplasmosis. Isolation of strains of Toxoplasma gondii from domestic
animals. Nuovi Ann Ig Microbiol. 1964;15:545–51.
39. Munday BL. The epidemiology of toxoplasmosis with particular reference to
the Tasmanian environment. Parkville: Doctoral thesis, University of
Melbourne; 1970.
40. Al-Khalidi NW, Dubey JP. Prevalence of Toxoplasma gondii infection in
horses. J Parasitol. 1979;65:331–4.
41. Evers F, Garcia JL, Navarro IT, Zulpo DL, Nino Bde S, Ewald MP, et al.
Diagnosis and isolation of Toxoplasma gondii in horses from Brazilian
slaughterhouses. Rev Bras Parasitol Vet. 2013;22:58–63.
42. Khan A, Taylor S, Ajioka JW, Rosenthal BM, Sibley LD. Selection at a single
locus leads to widespread expansion of Toxoplasma gondii lineages that are
virulent in mice. PLoS Genet. 2009;5, e1000404.
43. Mercier A, Devillard S, Ngoubangoye B, Bonnabau H, Bañuls AL, Durand P,
et al. Additional haplogroups of Toxoplasma gondii out of Africa: population
structure and mouse-virulence of strains from Gabon. PLoS Negl Trop Dis.
2010;4, e876.
44. Fuentes I, Rubio JM, Ramirez C, Alvar J. Genotypic characterization of
Toxoplasma gondii strains associated with human toxoplasmosis in Spain:
direct analysis from clinical samples. J Clin Microbiol. 2001;39:1566–70.
45. Dubey JP, Vianna MC, Sousa S, Canada N, Meireles S, Correia da Costa JM,
et al. Characterization of Toxoplasma gondii isolates in free-range chickens
from Portugal. J Parasitol. 2006;92:184–6.
46. De Sousa S, Ajzenberg D, Canada N, Freire L, Da Costa JM, Darde ML, et al.
Biologic and molecular characterization of Toxoplasma gondii isolates from
pigs from Portugal. Vet Parasitol. 2006;135:133–7.
47. Antoniou M, Tzouvali H, Sifakis S, Galanakis E, Georgopoulou E, Tselentis Y.
Toxoplasmosis in pregnant women in Crete. Parassitologia. 2007;49:231–3.
48. Messaritakis I, Detsika M, Koliou M, Sifakis S, Antoniou M. Prevalent
genotypes of Toxoplasma gondii in pregnant women and patients from
Crete and Cyprus. Amer J Trop Med Hyg. 2008;79:205–9.
49. Vilares A, Gargaté MJ, Ferreira I, Martins S, Júlio C, Waap H, et al. Isolation
and molecular characterization of Toxoplasma gondii isolated from pigeons
and stray cats in Lisbon, Portugal. Vet Parasitol. 2014;205:506–11.
50. Dubey JP, Graham DH, Dahl E, Hilali M, El-Ghaysh A, Sreekumar C, et al.
Isolation and molecular characterization of Toxoplasma gondii from chickens
and ducks from Egypt. Vet Parasitol. 2003;114:89–95.
51. Khademvatan S, Saki J, Yousefi E, Abdizadeh R. Detection and genotyping
of Toxoplasma gondii strains isolated from birds in the southwest of Iran.
Brit Poultry Sci. 2013;54:76–80.
52. Frenkel JK. Pathogenesis of toxoplasmosis and of infections with organisms
resembling Toxoplasma. Ann NY Acad Sci. 1956;64:215–51.
53. Opsteegh M, Prickaerts S, Frankena K, Evers EG. A quantitative microbial risk
assessment for meatborne Toxoplasma gondii infection in The Netherlands.
Intl J Food Microbiol. 2011;150:103–14.
54. Opsteegh M, Schares G, Blaga R and van der Giessen J on behalf of the
consortium. Experimental studies of Toxoplasma gondii in the main livestock
species (GP/EFSA/BIOHAZ/2013/01). Final report. EFSA Supporting
Publications. 2016;13. doi:10.2903/sp.efsa.2016.EN-995.
55. Belluco S, Mancin M, Conficoni D, Simonato G, Pietrobelli M, Ricci A.
Investigating the determinants of Toxoplasma gondii prevalence in meat: a
systematic review and meta-regression. PLoS ONE. 2016;11:e0153856.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Klun et al. Parasites & Vectors  (2017) 10:167 Page 9 of 9
